Molecular Targets for the Treatment of Metastatic Colorectal Cancer

Over the past years, colorectal cancer (CRC) was subtyped according to its molecular and genetic characteristics, allowing the development of therapeutic strategies, based on predictive biomarkers. Biomarkers such as microsatellite instability (MSI), RAS and BRAF mutations, HER2 amplification or NTR...

Descripción completa

Detalles Bibliográficos
Autores principales: Cohen, Romain, Pudlarz, Thomas, Delattre, Jean-François, Colle, Raphaël, André, Thierry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563268/
https://www.ncbi.nlm.nih.gov/pubmed/32825275
http://dx.doi.org/10.3390/cancers12092350

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563268/
https://www.ncbi.nlm.nih.gov/pubmed/32825275
http://dx.doi.org/10.3390/cancers12092350

Ejemplares similares